TickerFacts.

A business in context

CORT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-15 · 0001193125-26-424350

  2. 4 · Ownership change

    Report date 2026-10-02 · 0001193125-26-414688

  3. 4 · Ownership change

    Report date 2026-10-01 · 0001193125-26-414684

  4. 4 · Ownership change

    Report date 2026-10-01 · 0001193125-26-414674

  5. 4 · Ownership change

    Report date 2026-10-01 · 0001193125-26-414667

  6. 4 · Ownership change

    Report date 2026-09-24 · 0001193125-26-405402

  7. 8-K · Current report

    Report date 2026-09-22 · 0001193125-26-398561 · Items 5.02,7.01,9.01

  8. 4 · Ownership change

    Report date 2026-09-16 · 0001193125-26-395837

  9. 4 · Ownership change

    Report date 2026-09-17 · 0001193125-26-395827

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-050613

  11. 8-K · Current report

    Report date 2026-07-29 · 0001628280-26-050607 · Items 2.02,7.01,9.01

  12. 8-K · Current report

    Report date 2026-06-17 · 0001193125-26-274258 · Items 8.01,9.01

  13. 8-K · Current report

    Report date 2026-05-19 · 0001193125-26-254622 · Items 8.01

  14. 8-K · Current report

    Report date 2026-05-21 · 0001628280-26-038793 · Items 5.02,5.07,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-028902

  16. 8-K · Current report

    Report date 2026-04-30 · 0001628280-26-028892 · Items 2.02,7.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-04-17 · 0001628280-26-025735

  18. 8-K · Current report

    Report date 2026-03-25 · 0001193125-26-123543 · Items 8.01,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-011091

  20. 8-K · Current report

    Report date 2026-02-24 · 0001628280-26-011080 · Items 2.02,7.01,9.01

  21. 8-K · Current report

    Report date 2026-02-19 · 0001193125-26-059551 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2026-01-22 · 0001193125-26-018704 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2025-12-31 · 0001193125-25-338184 · Items 8.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-048841

  25. 8-K · Current report

    Report date 2025-11-04 · 0001628280-25-048814 · Items 2.02,7.01

  26. 8-K · Current report

    Report date 2025-10-10 · 0001193125-25-237834 · Items 1.02,9.01

  27. 8-K · Current report

    Report date 2025-10-06 · 0001193125-25-231963 · Items 5.02,9.01

  28. 8-K · Current report

    Report date 2025-09-10 · 0001193125-25-199706 · Items 8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-037005

  30. 8-K · Current report

    Report date 2025-07-31 · 0001628280-25-036999 · Items 2.02,7.01

  31. 8-K · Current report

    Report date 2025-07-14 · 0001193125-25-158454 · Items 8.01,9.01

  32. 8-K · Current report

    Report date 2025-06-10 · 0001628280-25-031624 · Items 5.07,9.01

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-022173

  34. 8-K · Current report

    Report date 2025-05-05 · 0001628280-25-022167 · Items 2.02,7.01,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-04-25 · 0001628280-25-019942

  36. 8-K · Current report

    Report date 2025-03-31 · 0001193125-25-067871 · Items 8.01,9.01

  37. 8-K · Current report

    Report date 2025-03-03 · 0001193125-25-044123 · Items 8.01,9.01

  38. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-008167

  39. 8-K · Current report

    Report date 2025-02-26 · 0001628280-25-008131 · Items 2.02,7.01,9.01

  40. 8-K · Current report

    Report date 2024-12-30 · 0001193125-24-286917 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 60 transaction rows60SGrant / award: 12 transaction rows12AExercise / conversion: 34 transaction rows34MTax / exercise payment: 6 transaction rows6FGift: 8 transaction rows8G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

120 matching transaction rows. Showing 101 to 120.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-15
2026-07-17
WILSON JAMES NS · Sale
Disposed
Common Stock1978.089.49
2026-07-15
2026-07-17
WILSON JAMES NS · Sale
Disposed
Common Stock2974.088.81
2026-07-15
2026-07-17
Mokari AtabakM · Exercise / conversion
Acquired
Common Stock15833.019.26
2026-07-15
2026-07-17
Mokari AtabakS · Sale
Disposed
Common Stock101.089.43
2026-07-15
2026-07-17
Mokari AtabakS · Sale
Disposed
Common Stock3520.088.3
2026-07-15
2026-07-17
Mokari AtabakS · Sale
Disposed
Common Stock28460.087.89
2026-07-15
2026-07-17
Mokari AtabakS · Sale
Disposed
Common Stock7919.086.78
2026-07-15
2026-07-17
Mokari AtabakM · Exercise / conversion
Acquired
Common Stock24167.023.06
2026-07-15
2026-07-17
Mokari AtabakM · Exercise / conversion
Disposed
Stock option (right to buy)
Derivative security
24167.00.0
2026-07-15
2026-07-17
Mokari AtabakM · Exercise / conversion
Disposed
Stock option (right to buy)
Derivative security
15833.00.0
2026-07-07
2026-07-08
Guyer WilliamM · Exercise / conversion
Acquired
Common Stock20000.021.65
2026-07-07
2026-07-08
Guyer WilliamS · Sale
Disposed
Common Stock19048.093.11
2026-07-07
2026-07-08
Guyer WilliamS · Sale
Disposed
Common Stock952.093.54
2026-07-07
2026-07-08
Guyer WilliamM · Exercise / conversion
Disposed
Stock Option (right to buy)
Derivative security
20000.00.0
2026-07-01
2026-07-06
Maduck SeanS · Sale
Disposed
Common Stock11024.087.33
2026-07-01
2026-07-06
Maduck SeanS · Sale
Disposed
Common Stock2801.088.51
2026-07-01
2026-07-06
Maduck SeanM · Exercise / conversion
Acquired
Common Stock25000.08.27
2026-07-01
2026-07-06
Maduck SeanS · Sale
Disposed
Common Stock11175.089.31
2026-07-01
2026-07-06
Maduck SeanM · Exercise / conversion
Disposed
Stock option (right to buy)
Derivative security
25000.00.0
2026-05-27
2026-07-08
Robb Gary CharlesG · Gift
Disposed
Common Stock600.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001088856CORCEPT THERAPEUTICS INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Corcept Therapeutics · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$675.04M$725.06M
2023-12-31$482.38M$533.38M
2022-12-31$401.86M$462.59M
2021-12-31$365.98M$455.00M
2020-12-31$353.87M$460.70M
2019-12-31$306.49M$403.90M
2018-12-31$251.25M$337.11M
2017-12-31$159.20M$218.83M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗